Drug Topics November 2021

November 17, 2021

The FDA has approved finerenone (Kerendia, Bayer) for the treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes.

November 17, 2021

This occasional “reward” hardly makes up for the belligerent customers, insurance issues, and—yes—stressed-out pharmacists.

November 16, 2021

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.

November 16, 2021

Sleep disorders can mimic symptoms of ADHD and providers should have a high index of suspicion when screening a patient for these conditions.

November 16, 2021

Learn more about controlling pediatric type 1 diabetes through pharmacist recommendations and families who address common misconceptions.

November 15, 2021

The CDC estimates that 83 million Americans have prediabetes and that 84% of them don’t know it and community pharmacy can play a major role in preventing diabetes.

November 15, 2021

Women make up to 80% of health care decisions in the United States, but for some, biosimilar knowledge is lacking.

November 15, 2021

During a session at the 2021 American Academy of Pediatrics National Conference & Exhibition research revealed that introduction to common allergy foods early on can be key in decreasing the frequency of development in children.

November 15, 2021

Continued vigilance is needed in the health care field to only prescribe antibiotics when they are truly needed.

November 12, 2021

Omalizumab (Xolair) is the oldest available biologic for asthma and is anti–IgE. Mepolizumab, an anti–IL-5 biologic, has been shown to reduce exacerbations and eosinophils and result in improved markers of control.

November 12, 2021

Vaccine technologies in development may facilitate a rapid and effective response to new threats and likely will target not only infectious diseases but also allergies, autoimmune conditions, and cancers.

November 11, 2021

Help patients (and parents) change their behavior by speaking clearly, using data, and remaining nonjudgmental.

September 25, 2021

A CE session during the 2021 Total Pharmacy Solutions Summit illuminated the ways that patient-centered communication can improve outcomes and enhance the pharmacist’s role in health care.